Assistance Publique des Hôpitaux de Paris SA
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1849-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.aphp.fr
Satisfaction of HIV-infected Patients Treated With Cabotegravir-rilpivirine Injectable Dual Therapy
- Conditions
- HIV Infections
- First Posted Date
- 2023-01-25
- Last Posted Date
- 2023-01-25
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 150
- Registration Number
- NCT05697289
Risk of Incident IMID in Patients Treated With Biologics and Immunosuppressive Drugs for a Single IMID
Active, not recruiting
- Conditions
- Inflammatory Disease
- First Posted Date
- 2023-01-25
- Last Posted Date
- 2023-04-24
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 750000
- Registration Number
- NCT05696106
- Locations
- 🇫🇷
Hôpital Saint-Antoine, Paris, France
Evaluation of TNF-alpha Antagonists (Infliximab) Withdrawal in Sarcoidosis
Phase 3
Recruiting
- Conditions
- Sarcoidosis
- Interventions
- Drug: STOP arm
- First Posted Date
- 2023-01-19
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 90
- Registration Number
- NCT05689879
- Locations
- 🇫🇷
Hôpital de la Pitié-Salpêtrière, Paris, France
Study of Bladder-sphincter Symptoms in Functional Neurological Disorders
Recruiting
- Conditions
- Urinary Bladder Sphincter Disorder
- First Posted Date
- 2023-01-19
- Last Posted Date
- 2023-08-23
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 150
- Registration Number
- NCT05689866
- Locations
- 🇫🇷
Hospital Avicenne-Neurology, Bobigny, France
Oral Glibenclamide in Preterm Infants with Hyperglycaemia (GALOP)
Phase 2
Recruiting
- Conditions
- Transient; Hypoglycemia, NeonatalPretermGlibenclamide Adverse Reaction
- Interventions
- Biological: Pharmacokinetics studyBiological: C-peptide proinsulin ratioBiological: Blood glucose on fluorinated tubeBiological: Routine biological monitoringBiological: glycose holter monitor
- First Posted Date
- 2023-01-18
- Last Posted Date
- 2025-01-20
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 45
- Registration Number
- NCT05687500
- Locations
- 🇫🇷
Hopital Necker - Enfants malades, Paris, France
DIrect Oral Anticoagulation and mechaNical Aortic Valve
- First Posted Date
- 2023-01-18
- Last Posted Date
- 2023-01-26
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 1044
- Registration Number
- NCT05687448
- Locations
- 🇫🇷
Service de Cardiologie Hôpital Lariboisière, Paris, France
Evaluation of the Quality of Life Induced by the Cinnamon Anti-odor Dressing in Patients With Malodorous Wounds
Not Applicable
Recruiting
- Conditions
- Malodorous Wounds (Chronic, Malignant or Infected Wounds)
- Interventions
- Other: Charcoal dressingOther: Cinnamon dressing
- First Posted Date
- 2023-01-17
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 98
- Registration Number
- NCT05685628
- Locations
- 🇫🇷
Hospitalisation à Domicile AP-HP, Paris, France
🇫🇷Hospitalisation à domicile Fondation Santé Service, Levallois-Perret, France
🇫🇷Hôpital Sainte Périne, Paris, France
Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis
Phase 4
Recruiting
- Conditions
- Sepsis
- Interventions
- Drug: intermittent pivotal βL-ABDrug: continuous pivotal βL-AB
- First Posted Date
- 2023-01-12
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 600
- Registration Number
- NCT05681442
- Locations
- 🇫🇷
Médecine Intensive Réanimation - Hôpital Croix Rousse, Lyon, France
🇫🇷Réanimation Chirurgicale - Saint Eloi, Montpellier, France
🇫🇷Médecine Intensive Réanimation - Pasteur 2, Nice, France
Epicardial Adipose Tissue and Arterial Stiffness in People Living With Diabetes (METAB-CV-PWV)
Recruiting
- Conditions
- Diabetic Patients
- First Posted Date
- 2023-01-12
- Last Posted Date
- 2023-01-12
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 400
- Registration Number
- NCT05681533
- Locations
- 🇫🇷
endocrinologie site, Avicenne hospital, Bobigny, France
Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Kidney Transplant Recipients (OPTI-TREX)
Phase 4
Recruiting
- Conditions
- Pediatric Kidney Transplant Recipients
- Interventions
- Drug: Usual dose adjustment of enoxaparinDrug: Bayesian based dose adjustment of enoxaparin
- First Posted Date
- 2023-01-05
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 50
- Registration Number
- NCT05672550
- Locations
- 🇫🇷
Hôpital Necker - Enfants malades, Paris, Ile-de-France, France
🇫🇷Hôpital Pellegrin, Bordeaux, France
🇫🇷CHU Félix Guyon, La Réunion, France
© Copyright 2025. All Rights Reserved by MedPath